Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,397 hedge funds and large institutions have $49.9B invested in Celgene Corp in 2018 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 528 increasing their positions, 615 reducing their positions, and 166 closing their positions.
5% less funds holding
Funds holding: 1,470 → 1,397 (-73)
14% less repeat investments, than reductions
Existing positions increased: 528 | Existing positions reduced: 615
19% less capital invested
Capital invested by funds: $61.8B → $49.9B (-$11.8B)
23% less call options, than puts
Call options by funds: $1.43B | Put options by funds: $1.85B
24% less funds holding in top 10
Funds holding in top 10: 55 → 42 (-13)
35% less first-time investments, than exits
New positions opened: 108 | Existing positions closed: 166
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$667M |
| 2 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$591M |
| 3 |
D.E. Shaw & Co
New York
|
+$339M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$315M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$306M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$592M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$518M |
| 3 |
Polen Capital Management
Boca Raton,
Florida
|
-$490M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$476M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$352M |
CELG Hedge Fund Activity: Q1 2018 in Review
1,397 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q1 2018, worth a combined $49.9B — down 19% from $61.8B a quarter earlier.
Sellers outnumbered buyers: 166 funds closed out of CELG and 108 opened new positions — a net loss of 58 holders — while 615 trimmed existing stakes and 528 added.
The largest buyer was Deutsche Bank, adding an estimated $667M. The largest seller was Jackson Square Partners, exiting entirely with an estimated $592M sold.
- 1,397 institutional investors held Celgene Corp (CELG) as of Q1 2018, down from 1,470 in Q4 2017.
- Funds reported $49.9B of Celgene Corp stock for Q1 2018, down 19% quarter-over-quarter.
- 108 funds opened new Celgene Corp positions in Q1 2018 and 166 closed out, a net change of -58 holders.
- The largest Celgene Corp buyer in Q1 2018 was Deutsche Bank, an estimated $667M added.
- The largest Celgene Corp seller in Q1 2018 was Jackson Square Partners, an estimated $592M sold.
Based on aggregated 13F filings for Q1 2018.